Kalkine has a fully transformed New Avatar.
Highlights
Morgan Stanley has upgraded Fortescue Metals Group (ASX: FMG) to "overweight," despite a less-than-optimistic iron ore price outlook affecting Australian miners. The decision reflects the analyst's belief that any near-term weakness in the iron ore market has already been priced into Fortescue’s shares heading …
Neuren Pharmaceuticals Limited (ASX:NEU) is an ASX-listed biopharmaceutical company, focusing on the development and commercialisation of novel treatments for neurological disorders. The company is making significant progress with its lead products, DAYBUE™ (trofinetide) and NNZ-2591.
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine! Start Your 7-Days Free Trial Today!
Continue
AU
CA
NZ
UK
US
IND
Please wait processing your request...